Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 13, 2026
AXT, Inc. (AXTI) Stock Falls -50% Over the Past 30 Days: Key Factors Behind the Decline

AXT, Inc. (AXTI) Stock Falls -50% Over the Past 30 Days: Key Factors Behind the Decline

Key Takeaways

  • AXT, Inc. (AXTI) shares have plunged approximately 50% over the past 30 days, falling from $97.18 on June 12 to $48.55 as of mid-July 2026, marking one of the sharpest corrections in the semiconductor substrate sector.
  • The selloff represents a dramatic momentum unwind after the stock surged from roughly $2 in early 2025 to an all-time high of $143.16 in late May 2026, driven by AI-fueled demand for indium phosphide (InP) wafers.
  • Heavy insider selling by CEO Morris Young and multiple directors, combined with extreme valuation concerns and a broader semiconductor sector pullback, accelerated the decline despite several positive business developments.
  • Fundamental catalysts remain intact, including a three-year Coherent supply agreement, record InP backlog exceeding $100 million, and aggressive capacity expansion plans, but investor sentiment has shifted decisively negative in the short term.
  • The stock now trades below both its 20-day and 50-day moving averages, with a 14-day RSI in oversold territory at approximately 30.9, signaling deeply bearish near-term momentum.

Company Background and Market Position

AXT, Inc. is a global material science company that develops and manufactures high-performance compound and single-element semiconductor substrate wafers, including indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge). These substrates serve as foundational platforms for devices used in AI and data center connectivity, 5G infrastructure, passive optical networks, LED lighting, lasers, sensors, and satellite solar cells. Headquartered in Fremont, California, with major manufacturing operations in China, AXT is the world's largest InP substrate supplier. The company benefits from a vertically integrated manufacturing model, designing its own crystal-growth furnaces and controlling key raw materials through its supply chain. Investors closely follow AXTI for its exposure to the rapidly expanding optical networking market driven by AI infrastructure buildouts, making it a high-beta play on data center and photonics demand.

Recent Stock Performance: The 30-Day Correction

Over the last 30 days, AXTI shares have suffered a severe correction, dropping roughly 50% from $97.18 at the June 12 close to $48.55 as of mid-July. The decline accelerated in late June and early July, with the stock cascading through several key technical support levels, including the psychologically important $60 floor. Daily trading volume spiked dramatically during the initial leg down, with sessions exceeding 16 million shares, far above the three-month average of approximately 10.5 million. Over the broader quarter, AXTI's performance reflects a sharp boom-and-bust pattern: the stock rallied to an all-time high of $143.16 on May 26 before entering a brutal distribution phase that has erased roughly two-thirds of its value from peak levels. For the quarter overall, AXTI has declined approximately 27% from mid-April levels, though the peak-to-trough drawdown of roughly 66% tells a more dramatic story of momentum capital exiting a former highflier.

Drivers of the Recent Selloff

The 30-day collapse in AXTI shares stems from a confluence of factors, with momentum unwinding at the center. After a parabolic rally that carried the stock from roughly $20 in February to over $143 by late May, speculative capital that had piled into the name began aggressively rotating out. Insider selling added significant pressure: CEO Morris Young sold $14 million worth of shares at approximately $113 in early June, while directors David Chang and Jesse Chen collectively disposed of more than $1.6 million in stock during the same period. These transactions, while not unusual following such a dramatic price surge, rattled retail and institutional confidence. Broader semiconductor sector weakness also contributed, as names like MRVL and STX faced their own selloffs. ETF outflows from momentum-focused funds such as the Invesco Dorsey Wright Technology Momentum ETF (PTF), which counts AXTI among its holdings, amplified the downside. Valuation concerns mounted as the stock traded at a price-to-sales ratio above 20, leaving it vulnerable to any shift in sentiment. Notably, the selloff occurred despite a series of positive business developments, including a three-year InP supply agreement with Coherent Corp. and a $25.4 million long-term deal with Nanjing Casela Technologies. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Quarterly Performance Context

AXTI's quarterly performance captures one of the most volatile episodes in the stock's history. The first half of the quarter saw a euphoric rally driven by surging demand for InP wafers used in AI optical networking, with the company reporting first-quarter revenue of $26.9 million, up 38.7% year-over-year, and a narrower-than-expected loss. Investor optimism was further fueled by management's announcement of plans to double InP production capacity in 2026—and again in 2027—backed by a $632.5 million capital raise. The stock hit its all-time high of $143.16 on May 26 before the narrative abruptly reversed. A combination of profit-taking, insider sales, the absence of near-term profitability, and a risk-off rotation in high-momentum semiconductor stocks triggered a cascading selloff throughout June. By early July, even constructive news such as the Coherent supply agreement and a new board appointment could not stabilize the stock. The quarterly trajectory underscores the extreme sensitivity of AXTI to shifts in momentum and risk appetite, as the same AI tailwind that lifted the stock to record highs was not enough to prevent a rapid mean reversion once sellers took control.

Navigating Volatility with AI Trading Tools

As semiconductor stocks like AXTI experience heightened volatility, I often turn to AI-driven tools to help navigate rapid price swings. Tickeron's Trending AI Robots page offers a curated selection of the platform's top-performing AI trading bots from a universe of hundreds covering thousands of tickers. These bots employ diverse strategies—ranging from swing trading to trend following—and are designed to adapt to shifting market conditions across multiple timeframes. The Trending AI Robots section highlights only the most relevant and consistently performing bots, making it a practical resource for traders seeking data-driven insights and real-time trade signals without the emotional bias that often accompanies manual decision-making. From what I see, this kind of tool can provide an objective lens when sentiment turns sharply negative.

Key Factors to Monitor Going Forward

Looking ahead, AXTI's second-quarter 2026 earnings release on July 30 represents the most immediate and consequential catalyst. Investors will closely scrutinize revenue growth, gross margin trends, and management's forward guidance, particularly regarding the ramp-up of InP production capacity and the timeline for achieving sustained profitability. The status of U.S. export permits for InP products remains a critical regulatory overhang that could materially impact access to key American customers. The company's record InP backlog exceeding $100 million and long-term supply agreements with Coherent and Nanjing Casela provide a strong demand foundation, but execution on capacity expansion and margin improvement will determine whether the stock can stabilize. Macroeconomic factors, including AI infrastructure spending trends, semiconductor industry cyclicality, and trade relations between the U.S. and China given AXT's manufacturing footprint, also warrant close monitoring. From a technical perspective, the $53 support level and the ability to reclaim the $62-$65 zone will be key indicators of whether this correction is approaching a bottom or has further downside to the $40 area. I'm watching this closely as the next earnings print could clarify the path ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: AXTI

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


AXTI in upward trend: price rose above 50-day moving average on August 06, 2026

AXTI moved above its 50-day moving average on August 06, 2026 date and that indicates a change from a downward trend to an upward trend. In of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on AXTI as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AXTI just turned positive on July 21, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AXTI moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AXTI broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AXTI entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock slightly worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.737) is normal, around the industry mean (9.013). AXTI's P/E Ratio (2583.333) is considerably higher than the industry average of (176.968). AXTI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.654). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (32.051) is also within normal values, averaging (38.579).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 67.85B. The market cap for tickers in the group ranges from 555.66K to 694.76B. ASML holds the highest valuation in this group at 694.76B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 7%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 46%. ONTO experienced the highest price growth at 26%, while SMTK experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 1%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 32
Price Growth Rating: 44
SMR Rating: 74
Profit Risk Rating: 60
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
AXTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufactures of high-performance compound semiconductor substrates

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
4281 Technology Drive
Phone
+1 510 438-4700
Employees
1075
Web
http://www.axt.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.